Agenus
This account is verified because it's an official organization on X. Learn more@Agenus_Bio
Our mission is to harness the power of the immune system to bring therapies with curative intent to individuals living with cancer. bit.ly/4eXrlgY
1.1K Following 2.8K Followers 1.5K Posts
Latest posts 5
New at @sitcancer’s #SITC2026: more than half of patients in our Phase 1b MSS mCRC cohort achieved long-term survival on BOT+BAL, and some remain alive and off all cancer therapy. Read more in our press release: bit.ly/4y9S81U
0:53
Agenus reported third quarter 2026 financial results, highlighting progress toward Phase 3 ROBBIN initiation, new clinical evidence from NEST and UNICORN, and the first BOT+BAL marketing authorizations in Armenia. Read the full press release: bit.ly/3KSL3Qw
0:23
Results from UNICORN, the Phase 2 trial for BOT+BAL in preoperative colon cancer, have been published in @NatureMedicine, showing deep responses in MSS colon cancer and supporting continued advancement of ROBBIN, our planned Phase 3 trial. Read more: investor.agenusbio.com/news/default.a…
0:19
Preparations for Phase 3 ROBBIN are moving forward. Following ESMO, our medical team joined investigators and site teams in São Paulo, Brazil, to prepare for the study’s planned Q1 2027 opening, part of our ongoing work to ready sites worldwide.
0:15